11 results
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents (DOACS ... + Warfarin) Reference ... #DOAC #Dosing #Oral ... #Anticoagulation
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... and rivaroxaban are ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
►
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
with patients’ preference ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
to six months are ... utilize direct oral ... anticoagulants (DOACs ... #Management #Cardiology ... #INR #Target #DOAC
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
ANCA Vasculitis Management ... Algorithm - ACR ... High-Dose Daily Oral ... Options in Order of Preference ... ANCA #Vasculitis #Management
Malignant Hyperthermia is a very rare, but life-threatening condition that can occur after using certain anesthetic
steps involved in management ... #treatment #algorithm ... References: ... interventions are ... Management of malignant
Bacteremia Quick Reference - Treatment Duration

Gram Negative Bacteremia:
 • Avoid: Aminoglycosides and tigecycline
 • Catheters should
Bacteremia Quick Reference ... consider switching to oral ... blood cultures are ... drawn at 24 hours are ... Bacteremia #Treatment #Management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
pregnancy, maternal age ... sx overlap with normal ... Management during ... Avoid Warfarin and DOAC ... suggest prophylactic anticoagulation
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
comorbidities, and preferences ... TB disease who are ... five effective oral ... following drugs are ... Tuberculosis #MDRTB #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
neuroexam - Oral ... Age 4. ... event, follow ACC algorithm ... Anticoagulation ... medical and surgical management